A coagulant for treating caprolactam terminal sewage and its preparation method and application

The coagulant prepared by modifying the polymerized aluminum sulfate, fruit charcoal and other components of the capsule polysaccharide, solved the problem of poor COD removal effect in the pigmented caprolactam sewage in the prior art, and achieved efficient COD, phosphorus and color degree removal, meet national emission standards and reduce treatment costs and time.

CN117756254BActive Publication Date: 2024-11-05YUEYANG LONGXING IND CORP
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202410025784.7
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2024-01-08
Publication Date
2024-11-05
Estimated Expiration
2044-01-08

AI Technical Summary

Technical Problem

The existing coagulants are poor in removing COD when treating end sewage of caprolactam in petrochemical industry, resulting in the need to increase the amount of coagulant or perform secondary reflow treatment, which increases the cost and treatment time, and cannot meet the discharge of high-concentration COD sewage. need.

Method used

The coagulant prepared by composite preparation of components such as capsular polysaccharide modified polymer aluminum sulfate, fruit charcoal, modified polymer iron sulfate, sodium polyacrylate and hydrolyzed polymaleic anhydride. The adsorption capacity is improved through the modification process. In order to treat caprolactam sewage, it can effectively remove COD, phosphorus and chromaticity.

Benefits of technology

This coagulant can make the COD content of the effluent after treatment less than 30 mg/L, significantly improve the COD removal rate and phosphorus removal effect, meet national emission standards, and reduce the treatment cost and time.

✦ Generated by Eureka AI based on patent content.
Patent Text Reader

Abstract

The present invention relates to the technical field of sewage treatment, and discloses a coagulant for treating caprolactam terminal sewage, and a preparation method and application thereof. The method comprises: (1) in the presence of a solvent and an initiator, capsular polysaccharide and polyaluminium sulfate are modified to obtain capsular polysaccharide modified polyaluminium sulfate; (2) fruit wood charcoal is first contacted with the capsular polysaccharide modified polyaluminium sulfate to obtain a mixture A; and in the presence of water, ferrous sulfate is mixed with an acid, an oxidant, and a catalyst to obtain a modified polyferric sulfate; (3) the modified polyferric sulfate is second contacted with the mixture A to obtain a mixture B; (4) the mixture B is contacted with sodium polyacrylate and hydrolyzed polymaleic anhydride in sequence for reaction. The coagulant provided by the present invention is used to treat caprolactam production sewage, and the treated effluent COD content is less than 30 mg / L, and has excellent treatment effects on phosphorus removal and chromaticity removal.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention relates to the technical field of sewage treatment, and in particular to a coagulant for treating caprolactam terminal sewage, and a preparation method and application thereof. Background Art

[0002] Coagulation is a summary of mixing, coagulation and flocculation, and refers to the process of agglomeration of colloidal particles and tiny suspended matter in water. Among them, coagulation refers to the destabilization process of colloids in water, while flocculation refers to the aggregation process of destabilized particles. The coagulation process is widely present in natural water bodies, accompanied by the migration and transformation of particulate matter and other pollutants in the water. Coagulation is widely used in water and wastewater treatment, and is one of the most commonly used, economical and main methods. Since the core technology of the coagulation process is the development and utilization of coagulants, the quality of coagulants is one of the key factors affecting the coagulation effect and even the entire water treatment effect. Therefore, the development of multifunctional, efficient and high-quality coagulant products aims to improve water treatment effects, reduce costs and expand application areas.

[0003] The basicity of polyferric sulfate (PFS) is generally not too high, generally between 8% and 16%. When the basicity value is outside this range, the hydrolysis reaction of iron ions will change greatly, from inorganic high-valent complexes to inorganic low-valent gelling substances. The coagulation effect on sewage impurities is mainly due to the strong adsorption of colloidal particles by the multi-nuclear complexes produced during its hydrolysis. Through bonding, bridging and cross-linking, the surface charge of particles and suspended matter reduces the potential, and the colloidal particles change from repulsion to attraction, destroying the stability of the micelle, and promoting the collision of colloidal particles, thereby forming flocculent coagulation precipitation. Therefore, polyferric sulfate has a very strong ability to remove colloids and various suspended matter in water. Compared with other organic flocculants and inorganic high molecular flocculants, polyferric sulfate has the following significant characteristics: good coagulation effect and fast sedimentation speed; wide application range, can adapt to various complex water quality systems; adapt to a wide range of pH values ​​in water; adapt to a wide temperature range, and can also exert its coagulation performance at low temperatures; small usage and low cost. However, it is highly corrosive to equipment, and some organic matter contained in water is more likely to react with Fe in iron salt coagulants. 3+ The formation of water-soluble contaminants causes coloration, thus limiting the use of polyferric sulfate.

[0004] Bacterial capsules have a strong adhesion effect and can adhere to tissue cells or inanimate surfaces. Bacterial capsules in wastewater biological treatment have a biological adsorption effect and can adsorb organic matter, inorganic matter and colloids in wastewater onto the surface of bacteria. Capsular polysaccharides, as the main component of bacterial capsules, have broad prospects in sewage treatment.

[0005] The quality of polyferric sulfate mainly depends on two indicators, namely the total iron content and basicity, among which basicity is particularly important. Basicity, also known as alkalinity, indicates the proportion of light groups (OH") in the molecules of a substance. It is an important technical indicator related to product stability and coagulation performance. Low-basicity polyferric sulfate has good stability, which makes its bonding, bridging, adsorption, electrical neutralization and compression of double electric layer better than high-basicity polyferric sulfate, while high-basicity polyferric sulfate has better netting effect. The overall result is that the flocculation performance of low-basicity polyferric sulfate is significantly better than that of high-basicity polyferric sulfate. In the process of preparing polyferric sulfate, the oxidant addition method, reaction temperature, reaction time, raw material concentration, polymerization promoter and storage time all have an impact on the basicity.

[0006] Polyaluminium sulfate has the same flocculation performance as polyaluminium chloride (PAC), but it has better performance in removing high turbidity water, as well as decolorization, defluorination and low-temperature deturbidity performance. It has the advantages of both inorganic and organic coagulants, high efficiency, low consumption, low corrosiveness and a wide range of applications.

[0007] Generally, the end color of caprolactam wastewater is high, and it contains phosphorus and chemical oxygen demand (COD). However, the national Class A discharge standard allows COD discharge of less than or equal to 50 mg / L. However, the existing coagulant is usually a highly polymerized composite inorganic coagulant product with iron, aluminum, silicon and calcium as the main elements. It has strong adsorption and electrical neutralization, double layer compression and adsorption bridging capabilities. When added to wastewater, it can be quickly dispersed to achieve the effect of treating phosphorus, color and COD.

[0008] However, the existing single terminal treatment coagulant cannot achieve standard discharge for high-concentration wastewater. If COD needs to be removed to meet national emission standards, it can only be done by increasing the amount of coagulant or recirculating the treated wastewater for secondary treatment, which will increase the treatment cost and prolong the treatment time, and cannot meet the needs of removing high-concentration COD wastewater at the terminal treatment site of petrochemical wastewater.

[0009] Therefore, there is an urgent need to develop a new type of composite coagulant for treating petrochemical caprolactam terminal wastewater. Summary of the invention

[0010] The purpose of the present invention is to overcome the defect of the existing coagulant in that the COD removal effect on petrochemical caprolactam terminal sewage is not good.

[0011] In order to achieve the above object, the first aspect of the present invention provides a method for preparing a coagulant for treating caprolactam sewage, the method comprising:

[0012] (1) in the presence of a solvent and an initiator, modifying the capsular polysaccharide and polyaluminum sulfate to obtain capsular polysaccharide modified polyaluminum sulfate;

[0013] (2) contacting the fruit wood charcoal with the capsular polysaccharide-modified polyaluminium sulfate to obtain a mixture A; and

[0014] In the presence of water, ferrous sulfate is mixed with an acid, an oxidant and a catalyst to obtain modified polyferric sulfate; the basicity of the modified polyferric sulfate is 8%-10%;

[0015] (3) contacting the modified polymeric ferric sulfate with the mixture A for a second time to obtain a mixture B;

[0016] (4) contacting the mixture B with sodium polyacrylate and hydrolyzed polymaleic anhydride in sequence to obtain the coagulant.

[0017] The second aspect of the present invention provides a coagulant for treating caprolactam terminal wastewater prepared by the method described in the first aspect.

[0018] The third aspect of the present invention provides use of the coagulant described in the second aspect in treating caprolactam wastewater.

[0019] The coagulant prepared by compounding components such as capsule polysaccharide modified polyaluminum sulfate, fruit charcoal, modified polyferric sulfate, sodium polyacrylate, hydrolyzed polymaleic anhydride and the like has good adsorption capacity. When used for treating caprolactam production wastewater, the COD content of the treated effluent can be made less than 30 mg / L, and at the same time, the coagulant has excellent removal effects on phosphorus removal and chromaticity removal. DETAILED DESCRIPTION

[0020] The endpoints and any values ​​of the ranges disclosed in this article are not limited to the precise ranges or values, and these ranges or values ​​should be understood to include values ​​close to these ranges or values. For numerical ranges, the endpoint values ​​of each range, the endpoint values ​​of each range and the individual point values, and the individual point values ​​can be combined with each other to obtain one or more new numerical ranges, which should be considered as specifically disclosed in this article.

[0021] As mentioned above, the first aspect of the present invention provides a method for preparing a coagulant for treating caprolactam sewage, the method comprising:

[0022] (1) in the presence of a solvent and an initiator, modifying the capsular polysaccharide and polyaluminum sulfate to obtain capsular polysaccharide modified polyaluminum sulfate;

[0023] (2) contacting the fruit wood charcoal with the capsular polysaccharide-modified polyaluminium sulfate to obtain a mixture A; and

[0024] In the presence of water, ferrous sulfate is mixed with an acid, an oxidant and a catalyst to obtain modified polyferric sulfate; the basicity of the modified polyferric sulfate is 8%-10%;

[0025] (3) contacting the modified polymeric ferric sulfate with the mixture A for a second time to obtain a mixture B;

[0026] (4) contacting the mixture B with sodium polyacrylate and hydrolyzed polymaleic anhydride in sequence to obtain the coagulant.

[0027] Preferably, in step (1), the solvent is an ethanol aqueous solution with a mass fraction of 70-80 wt%.

[0028] The basicity of the modified polyferric sulfate in the present invention is determined by the GB / T 14591-2016 standard method.

[0029] Preferably, the mass ratio of the capsular polysaccharide to the solvent is 1:1-2.

[0030] Preferably, the mass ratio of the capsular polysaccharide, the polyaluminium sulfate and the initiator is 1:0.8-1.2:0.03-0.04. In this preferred case, the inventors of the present invention found that the obtained coagulant has better COD removal rate and phosphorus removal effect.

[0031] Preferably, the initiator is selected from at least one of potassium persulfate and sodium persulfate.

[0032] Preferably, in step (2), the iodine value of the fruit wood charcoal is 750-900 mg / g, the methylene blue adsorption value is 8-30 mg / g, the average particle size is 50-150 μm, the moisture content is ≤6wt%, the ash content is ≤18wt%, and the pH value is 7-10. In this preferred case, the inventors found that the obtained coagulant has better COD removal rate and phosphorus removal effect.

[0033] Preferably, in step (2), the mass ratio of the capsular polysaccharide-modified polyaluminium sulfate to the fruit wood charcoal is 1:1-3.

[0034] The present invention has no particular limitation on the mixing in step (2), and those skilled in the art can perform the mixing according to the technical means known in the art. However, in order to obtain a coagulant with higher COD removal rate and better phosphorus removal effect, the present invention provides a preferred specific embodiment, in step (2), the mixing includes:

[0035] S1: In the presence of water, ferrous sulfate and an acid are first mixed to obtain a mixture I;

[0036] S2: performing a second mixing of the mixture I, an oxidant and a catalyst to obtain modified polyferric sulfate.

[0037] Preferably, the acid is titanium dioxide waste acid, and the content of hydrogen ions in the titanium dioxide waste acid is 30-40 g / L, and the content of sulfate ions is 1500-1800 g / L.

[0038] Preferably, in step S1, the dosage of the ferrous sulfate and the acid is controlled so that the molar ratio of sulfate to iron in the mixture I is 1:0.9-1.5. The inventors found that in this preferred case, the obtained coagulant has better COD removal rate and phosphorus removal effect.

[0039] In the present invention, the ferrous sulfate is at least one of anhydrous ferrous sulfate and ferrous sulfate containing crystal water; the ferrous sulfate containing crystal water is ferrous sulfate heptahydrate.

[0040] Preferably, in step S1, the mass ratio of the amount of ferrous sulfate to the amount of water is 0.2-0.3: 1. It should be noted that the amount of ferrous sulfate used here is calculated on a dry basis.

[0041] In the present invention, there is no particular limitation on the type of water, which may be tap water, deionized water, etc. Those skilled in the art may select the water according to their needs.

[0042] Preferably, in step S2, the catalyst is selected from at least one of sodium nitrite and sodium chlorate; and the oxidant is selected from at least one of oxygen and chlorine.

[0043] Preferably, in step S2, the molar ratio of the mixture I to the catalyst calculated as iron element is 1:0.05-0.15.

[0044] Preferably, in step S2, the oxidant is continuously introduced at a flow rate of 0.01-0.015 L / s until the reaction is completed.

[0045] According to a preferred embodiment, in step S1, the first mixing conditions at least meet the following conditions: temperature of 55-65°C, time of 50-90 min, stirring speed of 75-120 rpm.

[0046] According to another preferred embodiment, in step S2, the second mixing conditions at least meet the following conditions: temperature of 40-60°C, time of 60-120 min, and stirring speed of 75-120 rpm.

[0047] Preferably, in step (3), the mass ratio of the mixture A to the modified polymeric ferric sulfate is 1:98-100.

[0048] Preferably, in step (4), the contact reaction comprises: contacting the mixture B with sodium polyacrylate for the third time to obtain a mixture C; and contacting the mixture C with hydrolyzed polymaleic anhydride for the fourth time to obtain the coagulant.

[0049] Preferably, the weight average molecular weight of the sodium polyacrylate is 800-1000 g / mol, and the limiting viscosity is 0.05-0.1 dL / g. In this preferred case, the inventors found that the obtained coagulant has better COD removal rate and phosphorus removal effect. In the present invention, the weight average molecular weight of the sodium polyacrylate is tested by GPC column method, and the limiting viscosity is measured by GB / T22593-2008 standard.

[0050] Preferably, the mass ratio of the mixture B to sodium polyacrylate is 1-98: 1. More preferably, the mass ratio of the mixture B to sodium polyacrylate is 90-98: 1.

[0051] Preferably, the weight average molecular weight of the hydrolyzed polymaleic anhydride is 400-800 g / mol. Preferably, the hydrolyzed polymaleic anhydride is produced by Hebei Longke Water Treatment Co., Ltd.

[0052] Preferably, the mass ratio of the mixture C to the hydrolyzed polymaleic anhydride is 7-9:1.

[0053] According to a preferred embodiment, in step (1), the modification conditions at least meet the following conditions: temperature of 55-65° C., stirring speed of 130-170 rpm, and time of 7-9 h.

[0054] According to another preferred embodiment, in step (2), the conditions for the first contact at least meet the following requirements: temperature of 40-60°C, time of 70-120 min, and stirring speed of 95-155 rpm.

[0055] Preferably, in step (3), the conditions for the second contact at least meet the following requirements: temperature of 90-110° C., time of 70-120 min, and stirring speed of 95-155 rpm.

[0056] Preferably, in step (4), the conditions of the third contact at least meet the following conditions: temperature of 40-70°C, time of 20-40 min, and stirring speed of 155-200 rpm.

[0057] Preferably, the fourth contacting conditions at least meet the following conditions: temperature of 20-40° C., time of 1.5-2.5 h, and stirring speed of 155-200 rpm.

[0058] Preferably, the method for preparing a coagulant for treating caprolactam wastewater further comprises: in step (4), adjusting the pH value of the material after the fourth contact to 6-8 to obtain the coagulant. The present invention has no particular limitation on the method for adjusting the pH value, and those skilled in the art can use technical means known in the art, such as using a sodium hydroxide aqueous solution for adjustment.

[0059] In order to more specifically illustrate the method for preparing a coagulant for treating caprolactam sewage according to the first aspect of the present invention, a preferred specific embodiment is provided below for illustration:

[0060] (1) In the presence of a solvent and an initiator, the capsular polysaccharide and polyaluminum sulfate are modified at 55-65° C. and 130-170 rpm for 7-9 hours to obtain capsular polysaccharide modified polyaluminum sulfate;

[0061] (2) contacting the fruit wood charcoal with the capsular polysaccharide-modified polyaluminium sulfate at 40-60° C. and 95-155 rpm for 70-120 min to obtain a mixture A; and

[0062] In the presence of water, ferrous sulfate and acid are first mixed at 55-65° C. and 75-120 rpm for 50-90 min to obtain a mixture I; the mixture I is then secondly mixed with an oxidant and a catalyst at 40-60° C. and 75-120 rpm for 60-120 min to obtain a modified polymeric ferric sulfate; the basicity of the modified polymeric ferric sulfate is 8%-10%;

[0063] (3) contacting the modified polymeric ferric sulfate with the mixture A for a second time at 90-110° C. and 95-155 rpm for 70-120 min to obtain a mixture B;

[0064] (4) The mixture B is contacted with sodium polyacrylate for a third time at 40-70° C. and 155-200 rpm for 20-40 min to obtain a mixture C; the mixture C is then contacted with hydrolyzed polymaleic anhydride for a fourth time at 20-40° C. and 155-200 rpm for 1.5-2.5 h, and the pH value is adjusted to 6-8 to obtain the coagulant.

[0065] As mentioned above, the second aspect of the present invention provides a coagulant for treating caprolactam terminal wastewater prepared by the method described in the first aspect.

[0066] As mentioned above, the third aspect of the present invention provides the use of the coagulant described in the second aspect in treating caprolactam wastewater.

[0067] Preferably, the chemical oxygen demand (COD) in the caprolactam wastewater is 30-80 mg / L.

[0068] The present invention will be described in detail below by way of examples. In the following examples, unless otherwise specified, all the raw materials used are commercially available products. The water used in the following examples is tap water, and the room temperature is 25±3°C.

[0069] raw material:

[0070] Polyaluminium sulfate was purchased from Henan Jianke Purification Materials Co., Ltd.;

[0071] Solvent: ethanol aqueous solution, mass fraction 75wt%, purchased from Yueyang Xingjiao Chemical Co., Ltd.;

[0072] Initiator:

[0073] Potassium persulfate was purchased from Yueyang Xingjiao Chemical Co., Ltd.

[0074] Sodium persulfate was purchased from Yueyang Xingjiao Chemical Co., Ltd.;

[0075] Fruit charcoal:

[0076] Fruit wood charcoal I, iodine value is 800 mg / g, methylene blue adsorption value is 10 mg / g, average particle size is 74 μm; moisture content is 5wt%, ash content is 5wt%, pH value is 8, purchased from Shanghai Yuansen Activated Carbon Co., Ltd.;

[0077] Fruit wood charcoal II, iodine value 400 mg / g, methylene blue adsorption value 5 mg / g, average particle size 74 μm; moisture content 5wt%, ash content 4wt%, pH value 7, purchased from Shanghai Yuansen Activated Carbon Co., Ltd.;

[0078] Ferrous sulfate heptahydrate: industrial grade, purchased from Tongling Juneryuan Environmental Protection Technology Co., Ltd.;

[0079] Titanium dioxide waste acid: The hydrogen ion content is 36g / L, and the sulfate ion content is 1588g / L, provided by Tongling Juneryuan Environmental Protection Technology Co., Ltd.

[0080] Sodium nitrite, provided by Tongling Juneryuan Environmental Protection Technology Co., Ltd.;

[0081] Sodium polyacrylate: weight average molecular weight 850 g / mol, limiting viscosity 0.08 dL / g, purchased from Zhejiang Dongsheng Biotechnology Co., Ltd.;

[0082] Sodium hydroxide: analytical grade, purchased from Hunan Huihong Reagent Co., Ltd.;

[0083] Hydrolyzed polymaleic anhydride: weight average molecular weight 400-800 g / mol, purchased from Hebei Longke Water Treatment Co., Ltd.;

[0084] Cationic polyacrylamide: cationic degree is 40.08%, molecular weight is 10.45 million, purchased from Xinkemiao (Wuhan) Environmental Protection New Materials Co., Ltd.;

[0085] Capsular polysaccharide: provided by Shenzhen Aituo Chemical Co., Ltd., model capsular polysaccharide K98.

[0086] Preparation Example 1: Preparation of modified polyferric sulfate A1

[0087] S1: In the presence of water, 80 g of ferrous sulfate heptahydrate and titanium dioxide waste acid are first mixed to obtain a mixture I;

[0088] The amounts of ferrous sulfate heptahydrate and titanium dioxide waste acid are controlled so that the molar ratio of sulfate to iron in the mixture I is 1:0.9; the mass ratio of the amount of ferrous sulfate heptahydrate to the amount of water on a dry basis is 0.25:1;

[0089] The first mixing temperature is 60°C, the time is 70 min, and the stirring speed is 100 rpm;

[0090] S2: introducing oxygen into the reactor at a flow rate of 0.012 L / s, adding the mixture I and sodium nitrite into the reactor for a second mixing, and obtaining modified polyferric sulfate A1 with a basicity of 9%;

[0091] The molar ratio of the mixture I to the sodium nitrite calculated on the basis of the iron element is 1:0.1;

[0092] The temperature of the second mixing is 50° C., the time is 70 min, and the stirring speed is 100 rpm.

[0093] Preparation Example 2: Preparation of modified polyferric sulfate A2

[0094] This preparation example is carried out by a method similar to that of Preparation Example 1, except that in step S1, the amount of the ferrous sulfate and the titanium dioxide waste acid is controlled so that the molar ratio of the sulfate ion to the iron element in the mixture I is 1:1.8;

[0095] Modified polyferric sulfate A2 with a basicity of 11% was obtained.

[0096] Preparation Example 3: Preparation of modified polyferric sulfate A3

[0097] This preparation example is carried out by a method similar to that of Preparation Example 1, except that in step S2, the molar ratio of the mixture I to the oxidant in terms of iron element is 1:0.3;

[0098] Modified polyferric sulfate A3 with a basicity of 13% was obtained.

[0099] Example 1

[0100] A method for preparing a coagulant for treating caprolactam sewage, the method comprising:

[0101] (1) In the presence of an ethanol aqueous solution, 1 g of capsular polysaccharide is modified with polyaluminum sulfate and potassium persulfate to obtain capsular polysaccharide-modified polyaluminum sulfate; the mass ratio of the capsular polysaccharide to the polyaluminum sulfate and potassium persulfate is 1:1:0.034; the mass ratio of the capsular polysaccharide to the ethanol aqueous solution is 1:2;

[0102] The modification conditions are: temperature of 60°C, stirring speed of 150 rpm, and time of 8 h;

[0103] (2) taking 3 g of the capsular polysaccharide-modified polyaluminium sulfate and bringing it into first contact with fruit wood charcoal to obtain a mixture A; the mass ratio of the capsular polysaccharide-modified polyaluminium sulfate to the fruit wood charcoal is 1:1.6;

[0104] The first contacting temperature is 55°C, the time is 100 min, and the stirring speed is 100 rpm;

[0105] (3) contacting the modified polyferric sulfate A1 with the mixture A for a second time to obtain a mixture B; the mass ratio of the mixture A to the modified polyferric sulfate is 1:99;

[0106] The second contacting temperature is 100°C, the time is 100 min, and the stirring speed is 150 rpm;

[0107] (4) contacting the mixture B with sodium polyacrylate for the third time to obtain a mixture C; the mass ratio of the mixture B to the sodium polyacrylate is 98:1;

[0108] The third contacting temperature is 40°C, the time is 30 minutes, and the stirring speed is 160 rpm;

[0109] (5) contacting the mixture C with hydrolyzed polymaleic anhydride for the fourth time, and then adding sodium hydroxide to adjust the pH value of the solution to 7, to obtain coagulant T1; the mass ratio of the mixture C to the hydrolyzed polymaleic anhydride is 8:1;

[0110] The temperature of the fourth contact is 30° C., the time is 2 h, and the stirring speed is 180 rpm.

[0111] Example 2

[0112] A method for preparing a coagulant for treating caprolactam sewage, the method comprising:

[0113] (1) In the presence of an ethanol aqueous solution, 1 g of capsular polysaccharide is modified with polyaluminum sulfate and potassium persulfate to obtain capsular polysaccharide-modified polyaluminum sulfate; the mass ratio of the capsular polysaccharide to the polyaluminum sulfate and potassium persulfate is 1:1.2:0.04; the mass ratio of the capsular polysaccharide to the ethanol aqueous solution is 1:2;

[0114] The modification conditions are: temperature 65°C, stirring speed 130 rpm, and time 7 h;

[0115] (2) taking 3 g of the capsular polysaccharide modified polyaluminium sulfate and fruit wood charcoal for a first contact to obtain a mixture A; the mass ratio of the capsular polysaccharide modified polyaluminium sulfate to the fruit wood charcoal is 1:2.8;

[0116] The first contacting temperature is 40°C, the time is 120 min, and the stirring speed is 140 rpm;

[0117] (3) contacting the modified polyferric sulfate A1 with the mixture A for a second time to obtain a mixture B; the mass ratio of the mixture A to the modified polyferric sulfate A1 is 1:98;

[0118] The second contacting temperature is 110°C, the time is 70 min, and the stirring speed is 100 rpm;

[0119] (4) contacting the mixture B with sodium polyacrylate for the third time to obtain a mixture C; the mass ratio of the mixture B to the sodium polyacrylate is 95:1;

[0120] The third contacting temperature is 60°C, the time is 20 minutes, and the stirring speed is 180 rpm;

[0121] (5) contacting the mixture C with hydrolyzed polymaleic anhydride for the fourth time, and then adding sodium hydroxide to adjust the pH value of the solution to 7, to obtain coagulant T2; the mass ratio of the mixture C to the hydrolyzed polymaleic anhydride is 9:1;

[0122] The temperature of the fourth contact is 20° C., the time is 2.5 h, and the stirring speed is 160 rpm.

[0123] Example 3

[0124] This example adopts a method similar to that of Example 1 to prepare a coagulant for treating caprolactam wastewater; the difference is that in this example, the mass ratio of the capsular polysaccharide to polyaluminum sulfate and potassium persulfate in step (1) is 1:0.8:0.03;

[0125] In step (2), the mass ratio of the capsule polysaccharide modified polyaluminium sulfate to the fruit wood charcoal is 1:1;

[0126] In step (3), the mass ratio of the mixture A to the modified polymeric ferric sulfate A1 is 1:98;

[0127] In step (4), the mass ratio of the mixture B to sodium polyacrylate is 90:1;

[0128] In step (5), the mass ratio of the mixture C to the hydrolyzed polymaleic anhydride is 7:1;

[0129] The remaining conditions were the same as those in Example 1 to prepare coagulant T3.

[0130] Example 4

[0131] This example adopts a method similar to that of Example 1 to prepare a coagulant for treating caprolactam wastewater; the difference is that in this example, the mass ratio of the capsular polysaccharide to polyaluminum sulfate and potassium persulfate in step (1) is 1:1.5:0.034;

[0132] The remaining steps are the same as those in Example 1 to prepare coagulant T4.

[0133] Example 5

[0134] This embodiment adopts a method similar to that of Embodiment 1 to prepare a coagulant for treating caprolactam wastewater; the difference is that in this embodiment, the mass ratio of the mixture B to sodium polyacrylate is 80:1;

[0135] The remaining steps are the same as those in Example 1 to prepare coagulant T5.

[0136] Example 6

[0137] This embodiment adopts a method similar to that of Embodiment 1 to prepare a coagulant for treating caprolactam wastewater; the difference is that in this embodiment, the mass ratio of the mixture C to the hydrolyzed polymaleic anhydride is 5:1;

[0138] The remaining steps are the same as those in Example 1 to prepare coagulant T6.

[0139] Example 7

[0140] This embodiment adopts a method similar to that of embodiment 1 to prepare a coagulant for treating caprolactam wastewater; the difference is that the fruit wood charcoal I in embodiment 1 is replaced by an equal weight of fruit wood charcoal II;

[0141] The remaining steps were the same as those in Example 1 to prepare coagulant T7.

[0142] Comparative Example 1

[0143] This comparative example adopts a method similar to that of Example 1 to prepare a coagulant for treating caprolactam wastewater; the difference is that in this comparative example, no capsular polysaccharide is added in step (1);

[0144] The remaining steps are the same as those in Example 1 to prepare coagulant DT1.

[0145] Comparative Example 2

[0146] This comparative example adopts a method similar to that of Example 1 to prepare a coagulant for treating caprolactam wastewater; the difference is that the capsular polysaccharide in Example 1 is replaced by starch;

[0147] The remaining steps are the same as those in Example 1 to prepare coagulant DT2.

[0148] Comparative Example 3

[0149] This comparative example adopts a method similar to that of Example 1 to prepare a coagulant for treating caprolactam wastewater; the difference is that the modified polyferric sulfate A1 in Example 1 is replaced with modified polyferric sulfate A2;

[0150] The remaining steps are the same as those in Example 1 to prepare coagulant DT3.

[0151] Comparative Example 4

[0152] This comparative example adopts a method similar to that of Example 1 to prepare a coagulant for treating caprolactam wastewater; the difference is that the modified polyferric sulfate A1 in Example 1 is replaced with modified polyferric sulfate A3;

[0153] The remaining steps are the same as those in Example 1 to prepare coagulant DT4.

[0154] Comparative Example 5

[0155] This comparative example adopts a method similar to that of Example 1 to prepare a coagulant for treating caprolactam wastewater; the difference is that in this comparative example, modified polyferric sulfate is not added;

[0156] The remaining steps are the same as those in Example 1 to prepare coagulant DT5.

[0157] Test Case

[0158] Take 2L of caprolactam production wastewater sample (from the caprolactam production department of Sinopec Baling Petrochemical Co., Ltd., with a chemical oxygen demand of 47mg / L, a total phosphorus content of 0.06, a chromaticity of 40, and a pH value of 6.8) in a beaker, add 2g of the coagulant prepared in the above example or a commercially available coagulant (brand TYJ-30, purchased from Yangjing Water Treatment Chemical Factory Co., Ltd.) to the beaker, and stir for 2 minutes at room temperature and 80rpm; then adjust the pH value of the mixed solution in the beaker to 6.8 with a 1wt% sodium hydroxide solution, and stir for 5 minutes at room temperature and 80rpm; then add 3mL of a cationic polyacrylamide solution with a mass fraction of 50wt%, and stir for 3 minutes at room temperature and 80rpm; finally, let it stand for 30 minutes, and take the supernatant for detection. According to GB 11914-89 standard, the supernatant is tested for phosphorus content, chromaticity, and COD; the test results are shown in Table 1.

[0159] COD removal rate = (wastewater sample COD - supernatant COD) / wastewater sample COD × 100%;

[0160] Phosphorus removal rate = (total phosphorus content of sewage sample - phosphorus content of supernatant) / total phosphorus content of sewage sample × 100%;

[0161] Chroma removal rate = (A0-A) / A0×100%; A0 is the absorbance of the sewage sample, and A is the absorbance after sewage treatment;

[0162] Table 1

[0163] Coagulant No. COD removal rate / % Phosphorus removal rate / % Chroma removal / % T1 63.82 36 50 T2 51.06 35 40 T3 40.42 29 30 T4 31.91 31 30 T5 37.68 28 50 T6 38.93 25 40 T7 34.68 31 30 DT1 10.63 25 50 DT2 21.27 23 40 DT3 27.65 28 40 DT4 31.29 26 30 DT5 19.14 21 40 Commercially available coagulants 31.53 25 30

[0164] It can be seen from the results in Table 1 that the use of the coagulant of the present invention for treating caprolactam production wastewater has a good COD removal rate and phosphorus removal effect.

[0165] The preferred embodiments of the present invention are described in detail above, but the present invention is not limited thereto. Within the technical concept of the present invention, the technical solution of the present invention can be subjected to a variety of simple modifications, including the combination of various technical features in any other suitable manner, and these simple modifications and combinations should also be regarded as the contents disclosed by the present invention and belong to the protection scope of the present invention.

Claims

1. A method for preparing a coagulant for treating caprolactam sewage, characterized in that: The method includes: (1) In the presence of a solvent and an initiator, capsular polysaccharide and polyaluminum sulfate are modified to obtain capsular polysaccharide-modified polyaluminum sulfate; (2) contacting the fruit wood charcoal with the capsular polysaccharide-modified polyaluminium sulfate to obtain a mixture A; and In the presence of water, ferrous sulfate is mixed with an acid, an oxidant and a catalyst to obtain modified polyferric sulfate; the modified polyferric sulfate has a basicity of 8%-10%; (3) contacting the modified polyferric sulfate with the mixture A for a second time to obtain a mixture B; (4) contacting the mixture B with sodium polyacrylate and hydrolyzed polymaleic anhydride in sequence to obtain the coagulant; In step (1), the solvent is an ethanol aqueous solution with a mass fraction of 70-80wt%; The mass ratio of the capsular polysaccharide, the polyaluminium sulfate and the initiator is 1:0.8-1.2:0.03-0.04; The initiator is selected from at least one of potassium persulfate and sodium persulfate; In step (2), the acid is titanium dioxide waste acid, and the content of hydrogen ions in the titanium dioxide waste acid is 30-40 g / L, and the content of sulfate ions is 1500-1800 g / L; The catalyst is selected from at least one of sodium nitrite and sodium chlorate; the oxidant is selected from at least one of oxygen and chlorine.

2. The method according to claim 1, wherein: In step (2), the iodine value of the fruit wood charcoal is 750-900 mg / g, the methylene blue adsorption value is 8-30 mg / g, the average particle size is 50-150 μm; the moisture content is ≤6wt%, the ash content is ≤18wt%, and the pH value is 7-10; and / or In step (2), the mass ratio of the capsule polysaccharide modified polyaluminium sulfate to the fruit wood charcoal is 1:1-3; and / or In step (3), the mass ratio of the mixture A to the modified polyferric sulfate is 1:98-100; and / or In step (4), the weight average molecular weight of the sodium polyacrylate is 800-1000 g / mol, and the limiting viscosity is 0.05-0.1 dL / g; the weight average molecular weight of the hydrolyzed polymaleic anhydride is 400-800 g / mol.

3. The method according to claim 1 or 2, wherein: In step (2), the mixing includes: S1: In the presence of water, ferrous sulfate and an acid are first mixed to obtain a mixture I; S2: performing a second mixing of the mixture I, an oxidant and a catalyst to obtain modified polyferric sulfate.

4. The method according to claim 3, wherein: In step S1, the amounts of the ferrous sulfate and the acid are controlled so that the molar ratio of the sulfate radical to the iron element in the mixture I is 1:0.9-1.5; and / or In step S2, the molar ratio of the mixture I to the catalyst calculated on the basis of the iron element is 1:0.05-0.

15.

5. The method according to claim 3, wherein: In step S1, the first mixing conditions at least meet the following conditions: temperature of 55-65°C, time of 50-90 min, stirring speed of 75-120 rpm; and / or In step S2, the second mixing conditions at least meet the following conditions: temperature of 40-60°C, time of 60-120 min, stirring speed of 75-120 rpm.

6. The method according to claim 1 or 2, wherein: In step (4), the contact reaction comprises: The mixture B is contacted with sodium polyacrylate for the third time to obtain a mixture C; and the mixture C is contacted with hydrolyzed polymaleic anhydride for the fourth time to obtain the coagulant; The mass ratio of the mixture B to sodium polyacrylate is 1-98:1; the mass ratio of the mixture C to the hydrolyzed polymaleic anhydride is 7-9:

1.

7. The method according to claim 6, wherein: In step (1), the modification conditions at least meet the following conditions: temperature of 55-65°C, stirring speed of 130-170 rpm, and time of 7-9 h; and / or In step (2), the conditions of the first contact at least meet the following conditions: temperature of 40-60°C, time of 70-120 min, stirring speed of 95-155 rpm; and / or In step (3), the second contacting conditions at least meet the following conditions: temperature of 90-110°C, time of 70-120 min, stirring speed of 95-155 rpm; and / or In step (4), the conditions of the third contact at least meet the following requirements: temperature of 40-70°C, time of 20-40 min, stirring speed of 155-200 rpm; and / or The conditions of the fourth contact at least meet the following requirements: temperature of 20-40° C., time of 1.5-2.5 h, and stirring speed of 155-200 rpm.

8. A coagulant for treating caprolactam terminal sewage prepared by the method according to any one of claims 1 to 7.

9. Use of the coagulant according to claim 8 in treating caprolactam wastewater.